Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Johannes C. Reichert"'
Autor:
Maximilian Fischer, Lars Nonnenmacher, Johannes C. Reichert, Jürgen A. Bohnert, Evgeny A. Idelevich, Eyüp Doğan, Karsten Becker, Georgi I. Wassilew
Publikováno v:
Frontiers in Surgery, Vol 11 (2024)
This case-report focuses on a 23-year-old soldier suffering from a fracture-related hip joint infection (FRI) due to extensively drug-resistant Klebsiella pneumoniae and S. epidermidis. The patient underwent multiple septic revision surgeries includi
Externí odkaz:
https://doaj.org/article/bb187f74c7f84afca9e5ced1e11e75f4
Autor:
Andreas Nitsch, Sara Qarqash, Sarah Römer, Janosch Schoon, Axel Ekkernkamp, Maya Niethard, Johannes C. Reichert, Georgi I. Wassilew, Mladen V. Tzvetkov, Lyubomir Haralambiev
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 10, p 8669 (2023)
Although Ewing’s sarcoma (ES) is a rare, but very aggressive tumor disease affecting the musculoskeletal system, especially in children, it is very aggressive and difficult to treat. Although medical advances and the establishment of chemotherapy r
Externí odkaz:
https://doaj.org/article/c34b49000221400c8a11457b85c61a9b
Autor:
Johannes C. Reichert, Eberhard von Rottkay, Franz Roth, Tim Renz, Johannes Hausmann, Julius Kranz, Lars Rackwitz, Ulrich Nöth, Maximilian Rudert
Publikováno v:
BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-9 (2018)
Abstract Background The presented prospective randomized controlled single-centre study compares the clinical outcome up to 12 months after total hip arthroplasty using a minimally invasive single-incision direct anterior (DAA) and a direct transglut
Externí odkaz:
https://doaj.org/article/ba1c97926b8442279f914bb7d04fe2db
Publikováno v:
BMC Research Notes, Vol 10, Iss 1, Pp 1-5 (2017)
Abstract Background Necrotizing myositis is a rare but life-threatening soft-tissue infection characterized by rapidly spreading inflammation and subsequent necrosis of the affected tissue. The myositis is often caused by toxin-producing, virulent ba
Externí odkaz:
https://doaj.org/article/5718cbba91604341b54319bd44f96343
Autor:
David S. Sparks, Flavia M. Savi, Constantin E. Dlaska, Siamak Saifzadeh, Gary Brierly, Edward Ren, Amaia Cipitria, Johannes C. Reichert, Marie-Luise Wille, Michael A. Schuetz, Nicola Ward, Michael Wagels, Dietmar W. Hutmacher
Publikováno v:
Science Advances. 9
A preclinical evaluation using a regenerative medicine methodology comprising an additively manufactured medical-grade ε-polycaprolactone β-tricalcium phosphate (mPCL-TCP) scaffold with a corticoperiosteal flap was undertaken in eight sheep with a
Publikováno v:
Die Orthopädie. 52:3-11
Publikováno v:
Orthop Rev (Pavia)
Minimally invasive hip arthroplasty becomes increasingly popular. It is technically challenging and the approaches used are associated with a considerable learning curve. This nurtures concerns regarding patient safety, surgical training, and cost ef
Autor:
Manuela, Hoffmann, Johannes C, Reichert, Anastasia, Rakow, Janosch, Schoon, Georgi I, Wassilew
Publikováno v:
Orthopadie (Heidelberg, Germany)Literatur.
In 2020, more than 14,000 aseptic revision procedures for total hip arthroplasty (THA) were registered in Germany. Patient expectations of revision hip arthroplasty are not substantially different from expectations of primary hip replacement.However,
Autor:
Jacqui A. McGovern, Arne Berner, Flavia Medeiros Savi, Siamak Saifzadeh, Dietmar W. Hutmacher, Michael Schuetz, Amaia Cipitria, Constantin E. Dlaska, Johannes C. Reichert, Jiongyu Ren, Martin Wullschleger, Roland Steck, Michael Wagels, Maria A. Woodruff, David S. Sparks, Jan Henkel
Publikováno v:
Nature Protocols. 15:877-924
Critical-size bone defects, which require large-volume tissue reconstruction, remain a clinical challenge. Bone engineering has the potential to provide new treatment concepts, yet clinical translation requires anatomically and physiologically releva
Autor:
Ulrich Nöth, T. Geiser, E. von Rottkay, T. Kranich, M. Reyle-Hahn, Lars Rackwitz, Johannes C. Reichert
Publikováno v:
Der Orthopäde. 48:330-336
Fast-Track-Endoprothetik gewinnt im deutschsprachigen Raum immer mehr an Akzeptanz. Fast-Track-Programme versprechen durch eine Optimierung der Behandlungsprozesse eine schnellere Genesung, eine hohere Patientenzufriedenheit, eine Verbesserung der Qu